Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial

OBJECTIVE: To assess the feasibility, safety, and efficacy of intracoronary allogeneic cardiosphere-derived cells (CAP-1002) in patients with Duchenne muscular dystrophy (DMD). METHODS: The Halt Cardiomyopathy Progression (HOPE)-Duchenne trial is a phase I/II, randomized, controlled, open-label tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Michael, Jefferies, John, Byrne, Barry, Lima, Joao, Ambale-Venkatesh, Bharath, Ostovaneh, Mohammad R., Makkar, Raj, Goldstein, Bryan, Smith, Rachel Ruckdeschel, Fudge, James, Malliaras, Konstantinos, Fedor, Brian, Rudy, Jeff, Pogoda, Janice M., Marbán, Linda, Ascheim, Deborah D., Marbán, Eduardo, Victor, Ronald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396968/
https://www.ncbi.nlm.nih.gov/pubmed/30674601
http://dx.doi.org/10.1212/WNL.0000000000006950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396968/
https://www.ncbi.nlm.nih.gov/pubmed/30674601
http://dx.doi.org/10.1212/WNL.0000000000006950

Ejemplares similares